Legal Proceedings (Details) |
1 Months Ended | 3 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Jun. 27, 2025
USD ($)
|
Jun. 16, 2025
USD ($)
|
Jan. 08, 2025
USD ($)
|
Oct. 18, 2024
USD ($)
|
Apr. 30, 2025
USD ($)
|
Jun. 28, 2024
USD ($)
|
Oct. 08, 2024
claim
|
|
| SPEX Technologies, Inc. Lawsuit | Settled Litigation | |||||||
| Loss Contingencies [Line Items] | |||||||
| Loss contingency, pending claims, number | claim | 1 | ||||||
| Lump sum awarded | $ 1 | $ 1 | $ 316,000,000 | ||||
| Post judgement interest | $ 237,000,000 | ||||||
| Intellectual Property Litigation | Settled Litigation | |||||||
| Loss Contingencies [Line Items] | |||||||
| Post judgement interest | $ 6,000,000 | ||||||
| Global settlement | 130,000,000 | ||||||
| Litigation matter | $ 201,000,000 | ||||||
| Intellectual Property Litigation | Pending Litigation | |||||||
| Loss Contingencies [Line Items] | |||||||
| Aggregate liability for potential loss from litigation matter | $ 384,000,000 | ||||||
| Litigation matter | 291,000,000 | ||||||
| Noncurrent intangible assets to be amortized | $ 93,000,000 |
| X | ||||||||||
- Definition Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of gain from litigation settlement for amount awarded from other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Interest expense (income) directly attributable to an award in settlement of litigation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of damages awarded to the plaintiff in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of pending claims pertaining to a loss contingency. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|